Boateng-Kuffour, Adriana
Skrobanski, Hanna
Drahos, Jennifer
Kohli, Puja
Forster, Katie
Acaster, Sarah
Pakbaz, Zahra
Li, Nanxin
Williams, Kate
Funding for this research was provided by:
Vertex Pharmaceuticals Incorporated
Article History
Received: 15 December 2023
Accepted: 4 June 2024
First Online: 11 July 2024
Declarations
:
: The study was submitted for ethical review by WIRB-Copernicus Group Independent Review Board (IRB) and was granted an exemption (tracking number: 20217056). All participants gave their written informed consent online to participate in the study.
: All participants in this study consented to the publication of their de-identified data.
: AB-K, JD, PK, and NL are employees of Vertex Pharmaceuticals Incorporated and may hold stock or stock options in the company. HS, KF, and KW are employees of Acaster Lloyd Consulting and may hold stock or stock options in the company. SA is a company director of Acaster Lloyd Consulting. ZP has received research grants from Amgen, Pfizer, Novo Nordisk, Global Blood Therapeutics, Farma, and Novartis; consulting fees from Amgen, Dova, Global Blood Therapeutics, Guidepoint, Novartis, Sanofi, Sobi, and Vertex Pharmaceuticals Incorporated; has been a speaker for Dova, Global Blood Therapeutics, and Terumo; and has acted as a continuing medical education course director for the Cayenne Wellness Center and Children’s Foundation and planning committee member for their annual education symposium.